mTOR inhibition in COVID‐19: A commentary and review of efficacy in RNA viruses.

MLA

Karam, Basil S., et al. “MTOR Inhibition in COVID‐19: A Commentary and Review of Efficacy in RNA Viruses.” Journal of Medical Virology, vol. 93, no. 4, Apr. 2021, pp. 1843–46. EBSCOhost, https://doi.org/10.1002/jmv.26728.

APA

Karam, B. S., Morris, R. S., Bramante, C. T., Puskarich, M., Zolfaghari, E. J., Lotfi, E. S., Ingraham, N. E., Charles, A., Odde, D. J., & Tignanelli, C. J. (2021). mTOR inhibition in COVID‐19: A commentary and review of efficacy in RNA viruses. Journal of Medical Virology, 93(4), 1843–1846. https://doi.org/10.1002/jmv.26728

Chicago

Karam, Basil S., Rachel S. Morris, Carolyn T. Bramante, Michael Puskarich, Emily J. Zolfaghari, Emran, Sahar Lotfi, Nicholas E. Ingraham, Anthony Charles, David J. Odde, and Christopher J. Tignanelli. 2021. “MTOR Inhibition in COVID‐19: A Commentary and Review of Efficacy in RNA Viruses.” Journal of Medical Virology 93 (4): 1843–46. doi:10.1002/jmv.26728.